EN101
a 20-mer oligonucleotide that is chemically modified by the insertion of 2'-oxymethyl groups at the three terminal positions of the 3' end; selectively lowers AChE-R in blood and muscle yet leaves unaffected the synaptic variant AChE-S
Networked: 5
relevant articles (2 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Soreq, Hermona:
3 articles
(12/2012 - 10/2006)
|
2. | Argov, Zohar:
2 articles
(12/2012 - 01/2008)
|
3. | Brenner, Talma:
2 articles
(05/2006 - 04/2006)
|
4. | Hamra-Amitay, Yasmine:
2 articles
(05/2006 - 04/2006)
|
5. | Apolski, Slobodan:
1 article
(12/2012)
|
6. | Milic-Rasic, Vedrana:
1 article
(12/2012)
|
7. | Sussman, Jon:
1 article
(12/2012)
|
8. | Wirguin, Yitzhak:
1 article
(12/2012)
|
9. | Brawer, Solli:
1 article
(01/2008)
|
10. | Hazum, Eli:
1 article
(01/2008)
|
Related Diseases
Related Drugs and Biologics